|
Revenue
|
|
|
|
|
|
|
|
|
Total cost of revenue
|
|
$37.1m
|
$78.1m
|
$118.5m
|
$187.3m
|
$114.5m
|
$102.5m
|
|
Research and development
|
|
$9.4m
|
$21.6m
|
$29.4m
|
$28.8m
|
$29.4m
|
$26.2m
|
|
Sales and marketing
|
|
$5.4m
|
$14.0m
|
$20.9m
|
$19.2m
|
$18.4m
|
$19.5m
|
|
General and administrative
|
|
$16.6m
|
$26.0m
|
$55.3m
|
$44.7m
|
$54.3m
|
$43.2m
|
|
Impairment charge
|
|
—
|
—
|
—
|
—
|
—
|
$24.9m
|
|
Loss from operations
|
|
($35.7m)
|
($71.7m)
|
($104.3m)
|
($43.2m)
|
($41.8m)
|
($64.0m)
|
|
Interest income
|
|
—
|
—
|
—
|
$9.0m
|
$8.6m
|
$4.3m
|
|
Loss before income taxes
|
|
($37.0m)
|
($71.8m)
|
($101.7m)
|
($34.7m)
|
($33.4m)
|
($60.5m)
|
|
Net loss
|
|
($37.1m)
|
($72.0m)
|
($96.3m)
|
($34.6m)
|
($33.6m)
|
($60.6m)
|
|
Foreign currency translation adjustment
|
|
$235k
|
($226k)
|
($185k)
|
($40k)
|
$118k
|
$461k
|
|
Comprehensive loss
|
|
($36.9m)
|
($72.2m)
|
($96.5m)
|
($34.6m)
|
($33.5m)
|
($60.1m)
|
|
Net loss per common share basic
|
|
($4)
|
($1)
|
($0)
|
($0)
|
($0)
|
($0)
|
|
Net loss per common share diluted
|
|
($4)
|
($1)
|
($0)
|
($0)
|
($0)
|
($0)
|
|
Weighted-average number of shares used in computing net loss per share basic
|
|
9k
|
75k
|
196k
|
(0)
|
(0)
|
(0)
|
|
Weighted-average number of shares used in computing net loss per share diluted
|
|
9k
|
75k
|
196k
|
(0)
|
(0)
|
(0)
|
|
Interest expense
|
|
—
|
—
|
—
|
($397k)
|
($400k)
|
($378k)
|
|
Other (expense) income, net
|
|
($685k)
|
$55k
|
$595k
|
($116k)
|
$154k
|
($462k)
|
|
Income tax expense (benefit)
|
|
$149k
|
$115k
|
$5.4m
|
($108k)
|
$267k
|
$41k
|
|
Total operating expense
|
|
$31.4m
|
$61.6m
|
$105.6m
|
$92.7m
|
$102.1m
|
$88.9m
|